Thus, the inhibition of MSCs’ interaction with AML cells after CXCL12/CXCR4, CD44, ITG4 or E-selectin inhibition reduces the resistance of leukemic cells to chemotherapy [260,261,262,263,264,265]. The gene discussed is CXCL12; the disease is acute myeloid leukemia.